Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose crossover study of formoterol-HFA pMDI with spacer vs without in pediatric asthma
2006-000907-41Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of formoterol in asthma (3 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Percent FEV1 change from baseline at 3 hours post dose. Started Apr 2006; status: completed.
02
Drugs
formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2006-000907-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000907-41.